Raw material dependency and transport bottlenecks, not just production capacity, are the key challenges facing the EU’s radiopharmaceutical sector, according to the European Medicines Agency (EMA). Post navigation Trump tariffs live updates: Vance says good chance of UK trade deal as China warns of ‘unilateral bullying’Antoine Semenyo boosts Bournemouth’s charge for Europe after slender Fulham victory